- Home
- STNE vs ACLX Comparison
STNE vs ACLX Comparison
Compare STNE & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STNE
- ACLX
- Stock Information
- Founded
- STNE 2012
- ACLX 2015
- Country
- STNE Cayman Islands
- ACLX United States
- Employees
- STNE N/A
- ACLX N/A
- Industry
- STNE EDP Services
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- STNE Technology
- ACLX Health Care
- Exchange
- STNE Nasdaq
- ACLX Nasdaq
- Market Cap
- STNE 5.0B
- ACLX 4.4B
- IPO Year
- STNE 2018
- ACLX 2022
- Fundamental
- Price
- STNE $17.32
- ACLX $86.91
- Analyst Decision
- STNE Buy
- ACLX Strong Buy
- Analyst Count
- STNE 8
- ACLX 9
- Target Price
- STNE $17.44
- ACLX $117.78
- AVG Volume (30 Days)
- STNE 4.6M
- ACLX 416.8K
- Earning Date
- STNE 11-06-2025
- ACLX 11-05-2025
- Dividend Yield
- STNE N/A
- ACLX N/A
- EPS Growth
- STNE N/A
- ACLX N/A
- EPS
- STNE N/A
- ACLX N/A
- Revenue
- STNE $2,670,485,228.00
- ACLX $35,898,000.00
- Revenue This Year
- STNE $17.20
- ACLX N/A
- Revenue Next Year
- STNE $7.55
- ACLX $220.95
- P/E Ratio
- STNE N/A
- ACLX N/A
- Revenue Growth
- STNE 24.14
- ACLX N/A
- 52 Week Low
- STNE $7.72
- ACLX $47.86
- 52 Week High
- STNE $19.95
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- STNE 40.76
- ACLX 53.02
- Support Level
- STNE $16.30
- ACLX $84.50
- Resistance Level
- STNE $19.45
- ACLX $90.30
- Average True Range (ATR)
- STNE 0.58
- ACLX 3.56
- MACD
- STNE -0.22
- ACLX -0.36
- Stochastic Oscillator
- STNE 29.45
- ACLX 44.02
About STNE StoneCo Ltd.
StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services segment, which includes payments solutions, digital banking, credit, insurance solutions as well as the registry business. In the Software segment solution includes POS/ERP, TEF and QR Code gateways, reconciliation, CRM, OMS, e-commerce platform, engagement tool, ads solution, and marketplace hub. It generates the majority of its revenue from the Financial Services segment.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.